Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats

Calcified Tissue International

Volumn 72, Issue 4, 2003, Pages 519-527

  Hornby, S B ^a   Evans, G P ^a   Hornby, S L ^a   Pataki, A ^b   Glatt, M ^b   Green, J R ^b  

^a RICARDO UK LTD   (United Kingdom)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

BMD; Histomorphometry; Long term study; Maximum load; Ovariectomy; Zoledronic acid

Indexed keywords

ALENDRONIC ACID; BIOCHEMICAL MARKER; ETIDRONIC ACID; PAMIDRONIC ACID; RISEDRONIC ACID; ZOLEDRONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE DENSITY; BONE DISEASE; BONE STRENGTH; BONE STRUCTURE; BONE TURNOVER; CANCELLOUS BONE; CONTROLLED STUDY; DRUG EFFECT; ESTROGEN DEFICIENCY; MORPHOMETRICS; NONHUMAN; OSTEOCLAST; OVARIECTOMY; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RAT; REGRESSION ANALYSIS; TRABECULAR BONE;

ANIMALS; BONE AND BONES; BONE DENSITY; BONE RESORPTION; DIPHOSPHONATES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FEMUR; HUMANS; IMIDAZOLES; OSTEOPOROSIS, POSTMENOPAUSAL; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; WEIGHT-BEARING;

EID: 0042769110     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-002-2015-4     Document Type: Article

References (28)

1. Green JR, Müller K, Jaeggi KA (1994) Preclinical pharmacology of CGP 42'446, a potent, heterocyclic bisphosphonate compound. J Bone Miner Res 9:745-751
2. Müller K, Wiesenberg I, Jaeggi KA, Green JR (1998) Effects of the bisphosphonate zoledronate on bone loss in the ovariectomized and in the adjuvant arthritic rat. Drug Res 48:81-86
3. Pataki A, Müller K, Green JR, Ma YF, Li QN, Jee WSS (1997) Effects of short-term treatment with the bisphosphonates zoledronate and pamidronate on rat bone: a comparative histomorphometric study on cancellous bone formed before and during the treatment. Anat Rec 249:458-468
4. Wronski TJ, Yen CF, Scott KS (1991) Estrogen and diphosphonate treatment provide long-term protection against osteopenia in ovariectomized rats. J Bone Miner Res 6:387-394
5. Boyce RW, Wronski TJ, Ebert DC, Stevens ML, Paddock TA, Youngs TA (1995) Direct stereological estimation of three-dimensional connectivity in rat vertebrae: effect of estrogen, etidronate and risedronate following ovariectomy. Bone 16:209-213
6. Toolan BC, Shea M, Myers ER, Borchers RE, Seedor JD, Quartuccio H, Rodan G, Hayes WC (1992) Effects of 4-amino-1-hydroxybutylidene bisphosphonate on bone biomechanics in rats. J Bone Miner Res 7:1399-1406
7. Ohnishi H, Nakamura T, Narusawa K, Murakami H, Abe A, Barbier A, Suzuki K (1997) Bisphosphonate tiludronate increases bone strength by improving mass and structure in established osteopenia after ovariectomy in rats. Bone 21:335-343
8. Lalla S, Hothorn LA, Haag N, Bader R, Bauss F (1998) Lifelong administration of high doses of ibandronate increases bone mass and maintains bone quality in lumbar vertebrae in rats. Osteoporos Int 8:97-103
9. Romeis B (1989) Mikroskopische Technik, 17th ed. Urban Schwarzenberg, München
10. Miller SC, Bowman BM, Miller MA, Bagi CM (1991) Calcium absorption and osseous organ, tissue, and envelope-specific changes following ovariectomy in rats. Bone 12:439-446
11. Dawson AB (1925) The age order of epiphyseal union in the long bones of the albino rat. Anat Rec 31:1-17
12. Reitsma PH, Bijvoet OLM, Verlinden-Ooms H, van der Wee-Pals LJA (1980) Kinetic studies of bone and mineral metabolism during treatment with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) in rats. Calcif Tissue Int 32:145-157
13. Schenk R, Eggli P, Fleisch H, Rosini S (1986) Quantitative morphometric evaluation of the inhibitory activity of new aminobisphosphonates on bone resorption in the rat. Calcif Tissue Int 38:342-349
14. Wronski TJ, Lowry PL, Walsh CC, Ignaszewski LA (1985) Skeletal alterations in ovariectomized rats. Calcif Tissue Int 37:324-328
15. Tordjman C, Humeau A, Pastoureau P, Meunier F, Serkiz JP, Volland JP, Bonnet J (1994) Evaluation and comparison of urinary pyridinium crosslinks in two rat models of bone loss - ovariectomy and adjuvant polyarthritis - using a new automated HPLC method. Bone Miner 26:155-167
16. Chan EL-P, Awaminathan R (1998) Calcium metabolism and bone calcium content in normal and oophorectomized rats consuming various levels of saline for 12 months. J Nutr 128:633-639
17. Dick IM, Prince RL (1997) Estrogen effects on the renal handling of calcium in the ovariectomized perfused rat. Kidney Int 51:1719-1728
18. Aerssens J, van Audekercke R, Geusens P, Schot LPC, Osman AA-H, Dequeker J (1993) Mechanical properties, bone mineral content, and bone composition (collagen, osteocalcin, IGF-I) of the rat femur: influence of ovariectomy and nandrolone decanoate (anabolic steroid) treatment. Calcif Tissue Int 53:269-277
19. Dick IM, Prince RL (2000) The effect of estrogen on renal phosphorus handling in the rat. Am J Nephrol 21:323-330
20. i cotransport across renal brush border membranes from ovariectomized rats. Biochem Biophys Res Comm 221:442-445
21. Wronski TJ, Walsh CC, Ignaszewski LA (1986) Histologic evidence for osteopenia and increased bone turnover in ovariectomized rats. Bone 7:119-123
22. 2MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats. Calcif Tissue Res 11:196-214
23. Shen ML, Wronski TJ (1997) Time course of femoral neck osteopenia in ovariectomized rats. Bone 20:55-61
24. Azuma Y, Oue Y, Kanatani H, Ohta T, Kiyoki M, Komoriya K (1998) Effects of continuous alendronate treatment on bone mass and mechanical properties in ovariectomized rats: comparison with pamidronate and etidronate in growing rats. J Pharmacol Exp Ther 286:128-135
25. Frost HM (1998) From Wolff s law to the mechanostat: a new "face" of physiology. J Orthop Sci 3:282-286
26. Rodan GA (1997) Bone mass homeostasis and bisphosphonate action. Bone 20:1-4
27. Kollerup G, Thamsborg G, Bhatia H, Sorensen OH (1992) Quantitation of urinary hydroxypyridinium cross-links from collagen by high-performance liquid chromatography. Scand J Clin Lab Invest 52:657-662
28. Yoshimura Y, Ohnishi K, Hamamura M, Oda T, Sohda T (1993) Automated high-performance liquid chromatographic determination of hydroxylysylpyridinoline and lysylpyridinoline in urine using a column-switching method. J Chromatogr 613:43-49